PP121. HAPLOTYPE DIVERSITY OF BETA-GLOBIN GENES IN SERBIA
S. PAVLOVIC, B. Petrucev, N. Tosic, M. Stojiljkovic, T. Karan-Djurasevic, T. Kostic Institute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia and Montenegro e-mail: sonya@sezampro.yu
*Corresponding Author:
page: 102

Abstract

We present a detailed survey of the diversity of β-globin gene haplotypes in carriers of the most common β-thalassemia mutations (Hb Lepore Boston Washington-33%, codon 39 -22% and IVS-I-110 -17%) and normal betaA/betaA individuals of Serbian descent. We have studied eight linked polymorphic restriction enzyme sites along beta globin gene cluster (Hinc II/ε, Xmn I⁄ 5'Gγ, Hind III/Gγ, Hind III/Aγ, Hinc II/ψβ, Hinc II/3'ψβ, Ava II/β, Bam HI/3'β), as well as intragenic β-globin gene sequence diversity (frameworks) by using PCR-RFLP and sequencing analysis. Four different haplotypes associated with β-thalasse mia mutations were detected; two of them were typical of Mediterranean countries (I and V according to Orkin), and two were novel haplotypes, A (+--+--+--) and B (+--+--++). All the Lepore BW chromosomes were of the identical haplotype -haplotype A. Comparison of this novel haplotype associated with the Hb Lepore BW mutation in Serbia with haplotypes reported to date showed that it differs from all of them. These data support the hypothesis of the multicentric origin of this mutation. Haplotype analysis revealed that the codon 39 thalassemia mutation was associated with haplotype I and framework 1. However, in one family, codon 39 chromosomes were found to be associated with framework 2. Two different haplotypes (I and B) were associated with the IVS-I-110 thalassemic mutation. We presume that two most common Mediterranean mutations, codon 39 and IVS-I-110, have probably been introduced into Serbian population from Italy and Turkey, respectively, through historically documented migrations and settlements.




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006